Yeben Qian

Hefei, 230022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Navitoclax-encapsulated dual pH-responsive copolymeric nanoparticles improves hepatocellular carcinoma treatment with induction of apoptosis and immune activation.

Navitoclax-encapsulated dual pH-responsive copolymeric nanoparticles improves hepatocellular carcinoma treatment with induction of apoptosis and immune activation.

Journal: Journal of nanobiotechnology

Published: January 18, 2026

Integrated analysis of metabolic gene features and the immune microenvironment: identification of DPYD-mediated prognostic model and therapeutic targets in pancreatic cancer.

Integrated analysis of metabolic gene features and the immune microenvironment: identification of DPYD-mediated prognostic model and therapeutic targets in pancreatic cancer.

Journal: BMC gastroenterology

Published: December 03, 2025

Expression of Concern: Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.

Expression of Concern: Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: April 11, 2025

CARD9 promotes cholangiocarcinoma by regulating the IL-17A/Hedgehog and the THEM4/AKT/mTOR signaling pathways.

CARD9 promotes cholangiocarcinoma by regulating the IL-17A/Hedgehog and the THEM4/AKT/mTOR signaling pathways.

Journal: International immunopharmacology

Published: February 19, 2024

Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.

Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: May 03, 2022

A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study.

A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study.

Journal: Scientific reports

Published: October 12, 2021

Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in China.

Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in China.

Journal: World journal of gastrointestinal surgery

Published: October 19, 2020

Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis.

Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis.

Journal: World journal of surgical oncology

Published: August 05, 2020

Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.

Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.

Journal: EBioMedicine

Published: October 31, 2018

Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.

Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.

Journal: Clinics and research in hepatology and gastroenterology

Published: March 15, 2016

Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.

Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.

Journal: BMC cancer

Published: March 24, 2015

Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells.

Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: April 26, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026